01062nas a2200373   4500000000100000000000100001000000100002008004100003653001000044653001100054653004200065653001900107653007100126653001700197653004200214653002400256653003200280653002000312653001500332653001900347653001700366653002000383100001500403700001300418700001500431700001200446700001400458700001300472245013600485250001500621300001400636490000700650020003100657       2023                            d10aAdult10aHumans10a*Depression/drug therapy/epidemiology10aCohort Studies10a*Diabetes Mellitus, Type 2/complications/drug therapy/epidemiology10apolypharmacy10aAntidepressive Agents/therapeutic use10aPrimary health care10aUnited Kingdom/epidemiology10aAntidepressants10aDepression10aMultimorbidity10aprimary care10aType 2 diabetes1 aA. Jeffery1 aC. Bhanu1 aK. Walters1 aI. Wong1 aD. Osborn1 aJ. Hayes00aPolypharmacy and antidepressant acceptability in comorbid depression and type 2 diabetes: a cohort study using UK primary care data  a2023/04/28  ae392-e3980 v73  a0960-1643 (Print)0960-1643